{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T11:13:17Z","timestamp":1778065997754,"version":"3.51.4"},"reference-count":193,"publisher":"Informa UK Limited","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Expert Opinion on Pharmacotherapy"],"published-print":{"date-parts":[[2001,9]]},"DOI":"10.1517\/14656566.2.9.1415","type":"journal-article","created":{"date-parts":[[2005,5,4]],"date-time":"2005-05-04T21:15:06Z","timestamp":1115241306000},"page":"1415-1436","source":"Crossref","is-referenced-by-count":23,"title":["Primary Sj\u00f6gren\u2019s syndrome: oral aspects on pathogenesis, diagnostic criteria, clinical features and approaches for therapy"],"prefix":"10.1517","volume":"2","author":[{"given":"Birgitte","family":"Nauntofte","sequence":"first","affiliation":[{"name":"Department of Oral Pathology, Medicine and Physiology, School of Dentistry, University of Copenhagen N\u00f8rre All\u00e9 20, DK-2200 Copenhagen N, Denmark, Tel.: +45 35 32 67 29; Fax: +45 35 32 67 22;, E-mail: AMP@odont.ku.dk"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne Marie","family":"Pedersen","sequence":"additional","affiliation":[{"name":"Department of Oral Pathology, Medicine and Physiology, School of Dentistry, University of Copenhagen N\u00f8rre All\u00e9 20, DK-2200 Copenhagen N, Denmark, Tel.: +45 35 32 67 29; Fax: +45 35 32 67 22;, E-mail: AMP@odont.ku.dk"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2005,2,25]]},"reference":[{"key":"e_1_2_1_2_1","first-page":"1046","article-title":"Advances in the diagnosis and concept of Sjogren's syndrome (autoimmune exocrinopathy)","volume":"30","author":"STRAND V","year":"1980","unstructured":"STRAND V, TALAL N: Advances in the diagnosis and concept of Sjogren's syndrome (autoimmune exocrinopathy). Bull. Rheum. Dis. (1980) 30:1046\u20131050.","journal-title":"Bull. Rheum. Dis."},{"key":"e_1_2_1_3_1","doi-asserted-by":"crossref","unstructured":"MOUTSOPOULOS HM TALAL N: Immunological abnormalities in Sjogren's syndrome. In: Shigrert's Syndrome. Clinical and Immunological Aspects Talal N Moutsopoulos HM Kassan SS (Eds.) Springer Verlag Heidelberg (1987):258\u2013265.","DOI":"10.1007\/978-3-642-50118-0_24"},{"key":"e_1_2_1_4_1","doi-asserted-by":"crossref","unstructured":"MANTHORPE R OXHOLM E PRAUSE JU SCHIODT M: The Copenhagen criteria for Sjogrens syndrome. Scam\/. Rheumatol (1986) (Suppl. 61):19\u201321.","DOI":"10.1080\/15027732.1986.12461371"},{"key":"e_1_2_1_5_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-92-2-212"},{"key":"e_1_2_1_6_1","doi-asserted-by":"crossref","unstructured":"TALAL N: Recent developments in the immunology of Sjogren's syndrome (autoimmune exocrinopathy). Scam\/. Rheumatol. (1986) (Suppl. 61):76\u201382","DOI":"10.1080\/15027732.1986.12461384"},{"key":"e_1_2_1_7_1","doi-asserted-by":"crossref","unstructured":"KONTTINEN YT HUKKANEN M KEMPINEN P et al.: Peptide-containing nerves in labial salivary glands in Sjogren's syndrome. Arthritis Rheum. (1992) 7:815-820. **Immunohistochemical study demonstrating lack of peptide-containing nerves in central areas of focal lymphocytic infiltrates in labial salivary glands biopsies from patients with SS.","DOI":"10.1002\/art.1780350717"},{"key":"e_1_2_1_8_1","doi-asserted-by":"crossref","unstructured":"PEDERSEN AM DISSING S FAHRENKRUG J HANNIBAL J REIBEL J NAUNTOFTE B: Innervation pattern and Ca2+ signalling in labial salivary glands of healthy individuals and patients with primary Sjogren's syndrome. ..J. Oral. Path. Med. (2000) 29:97-109. \u2022\u2022A surprising finding of functional intactreceptor system on the surface membrane of labial salivary gland cells isolated from patients with pSS.","DOI":"10.1034\/j.1600-0714.2000.290301.x"},{"issue":"2","key":"e_1_2_1_9_1","first-page":"296","article-title":"Sympathetic dysfunction in patients with primary Sjogren's syndrome","volume":"28","author":"MANDL T","year":"2001","unstructured":"MANDL T, BORNMYR SV, CARSTENFORS J, JACOBSSON LT, MANTHORPE R, WOLLMER P: Sympathetic dysfunction in patients with primary Sjogren's syndrome. j Rheumatol (2001) 28(2):296\u2013301.","journal-title":"j Rheumatol"},{"key":"e_1_2_1_10_1","doi-asserted-by":"publisher","DOI":"10.1097\/00005792-196505000-00001"},{"key":"e_1_2_1_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/0049-0172(84)90001-5"},{"key":"e_1_2_1_12_1","doi-asserted-by":"crossref","unstructured":"OXHOLM E ASMUSSEN K: Primary Sjogren's syndrome: the challenge for classification of disease manifestations. mt. Med. (1996) 239:467-474. \u2022\u2022Proposal of a new classification system(wheel) for disease manifestations of SS.","DOI":"10.1046\/j.1365-2796.1996.482818000.x"},{"key":"e_1_2_1_13_1","unstructured":"WHALEY K BUCHANAN WW: Sjogren's syndrome and associated diseases. In: Clinical Immunology Vali Parker CW (Ed.) Saunders Philadelphia PA USA (1980):632\u2013666."},{"key":"e_1_2_1_14_1","unstructured":"HARLEY JB: Autoantibodies in Sjogren's syndrome. In: Shigrert's Syndrome. Clinical and Immunological Aspects. Talal N Moutsopoulos HM Kassan SS (Eds.) Springer Verlag Berlin Heidelberg New York London Paris Tokyo (1987):218\u2013234."},{"key":"e_1_2_1_15_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-89-6-888"},{"key":"e_1_2_1_16_1","first-page":"342","article-title":"GROSSIN M,KAHN MF: Primary Sjogren's syndrome (SS) and malignant lymphoma","volume":"24","author":"ZUFFEREY P","year":"1995","unstructured":"ZUFFEREY P, MEYER OC, GROSSIN M,KAHN MF: Primary Sjogren's syndrome (SS) and malignant lymphoma. Land. Rheumatol (1995) 24:342\u2013345.","journal-title":"Land. Rheumatol"},{"key":"e_1_2_1_17_1","unstructured":"MANTHORPE R KIRTAVA Z AXELL T HENRISSON V TABERY H JACOBSSON L. Clinical and demographic data at the time of diagnosis for primary Sjogren's syndrome. In: Shigreris Syndrome - State of the Ad. Proceedings of the Fourth International Symposium Tokyo Japan 1993. Homma M Sugai S Tojo T Miyasaka N Akizuki M (Eds.) Kugler Publications Amsterdam\/New York (1994):367\u2013369."},{"key":"e_1_2_1_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(81)80637-3"},{"key":"e_1_2_1_19_1","doi-asserted-by":"publisher","DOI":"10.1007\/s007840000070"},{"key":"e_1_2_1_20_1","first-page":"227","article-title":"The influence ofAge on Disease Manifestations and Serological Characteristics in Primary Sjogren's Syndrome","volume":"28","author":"HAGA HJ","year":"1999","unstructured":"HAGA HJ, JONSSON R: The influence ofAge on Disease Manifestations and Serological Characteristics in Primary Sjogren's Syndrome. Land. j Rheumatol (1999) 28:227\u2013232.","journal-title":"Land. j Rheumatol"},{"key":"e_1_2_1_21_1","first-page":"46","article-title":"Epidemiology of Sjogren's syndrome","volume":"24","author":"JACOBSSON LTH, MANTHORPE R","year":"1995","unstructured":"JACOBSSON LTH, MANTHORPE R: Epidemiology of Sjogren's syndrome. Rheumatol Europe (1995) 24:46\u201347.","journal-title":"Rheumatol Europe"},{"key":"e_1_2_1_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/0896-8411(89)90185-6"},{"key":"e_1_2_1_23_1","unstructured":"BJERRUM K: Primary Sjogren&apos;s syndrome and keratoconjunctivitis sicca: diagnostic methods frequency and social disease aspects. (Thesis). Munksgaard Copenhagen Denmark. Acta Opthalmol Scam\/. (2000) 78\\(Suppl. 231):1\u201337. \u2022An excellent overview and discussion of the diagnosis of KCS."},{"key":"e_1_2_1_24_1","doi-asserted-by":"publisher","DOI":"10.1177\/08959374960100010501"},{"key":"e_1_2_1_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0950-3579(05)80254-7"},{"key":"e_1_2_1_26_1","doi-asserted-by":"crossref","unstructured":"FOX RI ROBINSON CA CURD J MICHELSON P BONER HOWELL FV: First International Symposium on Sjogren's syndrome: suggested criteria for classification. Scand. j Rheumatol (1986) (Suppl. 61):28\u201330.","DOI":"10.1080\/15027732.1986.12461374"},{"key":"e_1_2_1_27_1","doi-asserted-by":"crossref","unstructured":"SKOPOULI FN DROSOS AA PAPAIOANNOU T MOUTSOPOULOS HM: Preliminary diagnostic criteria for Sjogren's syndrome. Scam\/. j Rheumatol (1986) (Suppl. 61):22\u201325.","DOI":"10.1080\/15027732.1986.12461372"},{"key":"e_1_2_1_28_1","doi-asserted-by":"crossref","unstructured":"HOMMA M TOJO T AKIZUKI M YAGAMATA H: Criteria for Sjogren's syndrome in Japan. Scam\/. I Rheumatol. (1986) (Suppl. 61):26\u201327.","DOI":"10.1080\/15027732.1986.12461373"},{"key":"e_1_2_1_29_1","first-page":"340","article-title":"Preliminary criteria for the classification of the Sjogren's syndrome","volume":"36","author":"VITALI C","year":"1993","unstructured":"VITALI C, BOMBARDIERI S, MOUTSOPOULOS HM et al: Preliminary criteria for the classification of the Sjogren's syndrome. Results of the prospective concerted action supported by the European Community. Arthritis Rheum. (1993) 36:340\u2013347.","journal-title":"Results of the prospective concerted action supported by the European Community. Arthritis Rheum."},{"key":"e_1_2_1_30_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.55.2.116"},{"key":"e_1_2_1_31_1","unstructured":"VITALI C BOMBARDIERI S MOUTSOPOULOS HM et al: The European classification criteria for Sjogren's syndrome (SS): proposal for a modification of the rules for classification suggested by the analysis of the receiver operating characteristic (ROC) curve of the criteria performance. j Rheumatol (1997) 24\\(Suppl. 50):38. Abstract. \u2022\u2022A proposed revision of the EEC criteriawould include antibodies to SS-A\/SS-B and\/or presence of focus 1."},{"key":"e_1_2_1_32_1","unstructured":"VITALI C BOMBARDIERI S MOUTSOPOULOS HM etal.: A proposal for modification of the European classification criteria for Sjogren's syndrome. Chit. Exp. Rheumatol (2000) 18:118. Abstract."},{"issue":"1","key":"e_1_2_1_33_1","first-page":"25","article-title":"Is sialography effective in diagnosing the salivary component of Sjogren's syndrome?Adv","volume":"10","author":"DANIELS TE","year":"1996","unstructured":"DANIELS TE, BENN DK: Is sialography effective in diagnosing the salivary component of Sjogren's syndrome?Adv. Dent. Res. (1996) 10(1):25\u201328.","journal-title":"Dent. Res."},{"key":"e_1_2_1_34_1","first-page":"279","article-title":"Sjogren's syndrome","volume":"42","author":"WHALEY K","year":"1973","unstructured":"WHALEY K, WILLIAMSON J, CHISHOLM DM, WEBB J, MASON DK, BUCHANAN WW: Sjogren's syndrome. I. Sicca components. Q. I Med. (1973) 42:279\u2013304.","journal-title":"I. Sicca components. Q. I Med."},{"key":"e_1_2_1_35_1","first-page":"577","article-title":"Hydrostatic sialography as an index of salivary gland disease in Sjogren's syndrome","volume":"11","author":"CHISHOLM DM","year":"1971","unstructured":"CHISHOLM DM, BLAIR GS, LOW PS, WHALEY K: Hydrostatic sialography as an index of salivary gland disease in Sjogren's syndrome. Acta Radial. (Diagn) (Stockholm). (1971) 11:577\u2013585.","journal-title":"Acta Radial. (Diagn) (Stockholm)."},{"key":"e_1_2_1_36_1","doi-asserted-by":"publisher","DOI":"10.1148\/97.1.91"},{"key":"e_1_2_1_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/0049-0172(80)90011-6"},{"key":"e_1_2_1_38_1","first-page":"119","article-title":"Criteria for the salivary component of Sjogren's syndrome","volume":"7","author":"SCHIODT M","year":"1989","unstructured":"SCHIODT M, THORN J: Criteria for the salivary component of Sjogren's syndrome. A review. Clin. Exp. Rheumatol (1989) 7:119\u2013122.","journal-title":"A review. Clin. Exp. Rheumatol"},{"key":"e_1_2_1_39_1","first-page":"131","article-title":"Parotid sialography and lip biopsy in the evaluation of oral component in Sjogren's syndrome","volume":"7","author":"VITALI C","year":"1989","unstructured":"VITALI C, MONTI P, GIUGGIOLI C et al.: Parotid sialography and lip biopsy in the evaluation of oral component in Sjogren's syndrome. Chit. Exp. Rheumatol (1989) 7:131\u2013135.","journal-title":"Chit. Exp. Rheumatol"},{"key":"e_1_2_1_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/0030-4220(86)90067-8"},{"key":"e_1_2_1_41_1","unstructured":"BERTRAM U: Xerostomia: clinical aspects pathology and pathogenesis. Acta Odontol Scam\/. (1967) 2: (Suppl. 49)."},{"key":"e_1_2_1_42_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI112954"},{"key":"e_1_2_1_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0901-5027(88)80151-6"},{"key":"e_1_2_1_44_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1971.03180390021005"},{"key":"e_1_2_1_45_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780220801"},{"key":"e_1_2_1_46_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0714.1992.tb00982.x"},{"key":"e_1_2_1_47_1","doi-asserted-by":"publisher","DOI":"10.3109\/03009749409099282"},{"key":"e_1_2_1_48_1","first-page":"103","article-title":"Magnetic Resonance Imaging of parotid glands and lip biopsy in the evaluation of xerostomia in Sjogren's syndrome","volume":"23","author":"VALESINI G","year":"1994","unstructured":"VALESINI G, GUALDI GF, PRIORI R et al.: Magnetic Resonance Imaging of parotid glands and lip biopsy in the evaluation of xerostomia in Sjogren's syndrome. Land. Rheumatol (1994) 23:103\u2013106.","journal-title":"Land. Rheumatol"},{"key":"e_1_2_1_49_1","doi-asserted-by":"publisher","DOI":"10.1148\/radiology.169.3.3055038"},{"key":"e_1_2_1_50_1","doi-asserted-by":"publisher","DOI":"10.1001\/archotol.1989.01860250107037"},{"key":"e_1_2_1_51_1","doi-asserted-by":"publisher","DOI":"10.1177\/00220345870660S107"},{"key":"e_1_2_1_52_1","first-page":"63","article-title":"BAUM BJ","volume":"122","author":"SHIP JA","year":"1991","unstructured":"SHIP JA, FOX PC, BAUM BJ. How much saliva is enough? 'Normal' function defined. J. Am. Dent. Assoc. (1991) 122:63\u201369.","journal-title":"How much saliva is enough? 'Normal' function defined. J. Am. Dent. Assoc."},{"key":"e_1_2_1_53_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780270205"},{"key":"e_1_2_1_54_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1601-0825.1999.tb00077.x"},{"key":"e_1_2_1_55_1","first-page":"637","article-title":"The European Community Study Group for Sjogren's syndrome","volume":"53","author":"VITALI C","year":"1994","unstructured":"VITALI C, MOUTSOPOULOS HM, BOMBARDIERI S et al: The European Community Study Group for Sjogren's syndrome. Sensitivity and specificity of tests for ocular and oral involvement in Sjogren's syndrome. Ann. Rheum. Dis. (1994) 53:637\u2013647.","journal-title":"Sensitivity and specificity of tests for ocular and oral involvement in Sjogren's syndrome. Ann. Rheum. Dis."},{"key":"e_1_2_1_56_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.51.4.499"},{"key":"e_1_2_1_57_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0714.1999.tb02045.x"},{"key":"e_1_2_1_58_1","doi-asserted-by":"publisher","DOI":"10.1016\/0030-4220(86)90313-0"},{"key":"e_1_2_1_59_1","doi-asserted-by":"publisher","DOI":"10.1034\/j.1601-0825.2001.70106.x"},{"key":"e_1_2_1_60_1","first-page":"437","article-title":"The importance of sialography for the determination of the parotid flow","volume":"72","author":"ERICSON S","year":"1971","unstructured":"ERICSON S: The importance of sialography for the determination of the parotid flow. The normal variation in salivary output in relation to the size of the gland at stimulation with citric acid. Acta Otolaryngol. (1971) 72:437\u2013444.","journal-title":"The normal variation in salivary output in relation to the size of the gland at stimulation with citric acid. Acta Otolaryngol."},{"key":"e_1_2_1_61_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780351119"},{"key":"e_1_2_1_62_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0889-857X(21)00317-3"},{"key":"e_1_2_1_63_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2842.1984.tb00565.x"},{"key":"e_1_2_1_64_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1741-2358.1997.00033.x"},{"key":"e_1_2_1_65_1","first-page":"453","article-title":"Salivary gland fluid secretion during aging","volume":"37","author":"BAUM BJ","year":"1989","unstructured":"BAUM BJ: Salivary gland fluid secretion during aging. J. Am. Cetiatr. Soc. (1989) 37: 453\u2013458.","journal-title":"J. Am. Cetiatr. Soc."},{"key":"e_1_2_1_66_1","doi-asserted-by":"publisher","DOI":"10.1093\/geronj\/48.5.M219"},{"key":"e_1_2_1_67_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-8177(87)54012-0"},{"key":"e_1_2_1_68_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0714.1989.tb01343.x"},{"key":"e_1_2_1_69_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0049-0172(97)80017-0"},{"key":"e_1_2_1_70_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0003-9969(99)90004-3"},{"key":"e_1_2_1_71_1","first-page":"318","article-title":"Major salivary gland function in primary Sjogren's syndrome and its relationship to clinical findings","volume":"17","author":"ATKINSON JC","year":"1990","unstructured":"ATKINSON JC, TRAVIS WD, PILLEMER SR et al.: Major salivary gland function in primary Sjogren's syndrome and its relationship to clinical findings. Rheumatol. (1990) 17:318\u2013322.","journal-title":"Rheumatol."},{"key":"e_1_2_1_72_1","unstructured":"PEDERSEN AM BARD OW A NAUNTOFTE B: Buffer Capacity of Parotid Saliva in Primary Sjogren's Syndrome. I Dent. Res. (2001). In Press."},{"key":"e_1_2_1_73_1","doi-asserted-by":"publisher","DOI":"10.3109\/00016489709114217"},{"key":"e_1_2_1_74_1","doi-asserted-by":"publisher","DOI":"10.1177\/00220345900690110401"},{"key":"e_1_2_1_75_1","doi-asserted-by":"publisher","DOI":"10.1177\/10454411930040030101"},{"key":"e_1_2_1_76_1","doi-asserted-by":"publisher","DOI":"10.1016\/0030-4220(74)90417-4"},{"key":"e_1_2_1_77_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.49.1.37"},{"key":"e_1_2_1_78_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780341019"},{"issue":"1","key":"e_1_2_1_79_1","first-page":"54","article-title":"Lower frequency of focal lip sialadenitis (focus score) in smoking patients","volume":"59","author":"MANTHORPE R","year":"2000","unstructured":"MANTHORPE R, BENONI C, KIRTAVA Z et al: Lower frequency of focal lip sialadenitis (focus score) in smoking patients. Can tobacco diminish the salivary gland involvement in Sjogren's syndrome? Ann. Rheum. Dis. (2000) 59(1):54\u201360.","journal-title":"Can tobacco diminish the salivary gland involvement in Sjogren's syndrome? Ann. Rheum. Dis."},{"key":"e_1_2_1_80_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0714.1986.tb00582.x"},{"key":"e_1_2_1_81_1","doi-asserted-by":"publisher","DOI":"10.1002\/anr.1780321005"},{"key":"e_1_2_1_82_1","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0714.2001.300102.x"},{"key":"e_1_2_1_83_1","first-page":"87","article-title":"Qualitative and quantitative observations on the histology of human labial salivary glands obtained post mortem","volume":"8","author":"SCOTT J","year":"1980","unstructured":"SCOTT J: Qualitative and quantitative observations on the histology of human labial salivary glands obtained post mortem. Biol. Buccale (1980) 8:87\u2013200.","journal-title":"Biol. Buccale"},{"key":"e_1_2_1_84_1","doi-asserted-by":"publisher","DOI":"10.1093\/ageing\/13.3.159"},{"key":"e_1_2_1_85_1","doi-asserted-by":"publisher","DOI":"10.1016\/0003-9969(77)90158-3"},{"key":"e_1_2_1_86_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0714.1986.tb00601.x"},{"key":"e_1_2_1_87_1","first-page":"379","article-title":"Focal adenitis in lacrimal and salivary glands","volume":"17","author":"SEGERBERG-KONTTINEN M","year":"1988","unstructured":"SEGERBERG-KONTTINEN M: Focal adenitis in lacrimal and salivary glands. A Post-mortem Study. Land. j Rheum. (1988) 17:379\u2013385.","journal-title":"A Post-mortem Study. Land. j Rheum."},{"key":"e_1_2_1_88_1","doi-asserted-by":"publisher","DOI":"10.1177\/00220345840630100101"},{"key":"e_1_2_1_89_1","first-page":"148","article-title":"Labial salivary gland biopsy in Sjogren's syndrome","volume":"40","author":"BODEUTSCH C","year":"1992","unstructured":"BODEUTSCH C, DE WILDE PCM, KATER L et al.: Labial salivary gland biopsy in Sjogren's syndrome. Netherlands J. Med. (1992) 40:148\u2013157.","journal-title":"Netherlands J. Med."},{"key":"e_1_2_1_90_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/32.7.578"},{"key":"e_1_2_1_91_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/28.4.293"},{"key":"e_1_2_1_92_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.0954-6820.1988.tb19634.x"},{"key":"e_1_2_1_93_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1056-8727(97)00047-0"},{"key":"e_1_2_1_94_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/36.12.1312"},{"key":"e_1_2_1_95_1","first-page":"932","article-title":"Significance of mucosal vs","volume":"113","author":"NAKHLEH RE","year":"1989","unstructured":"NAKHLEH RE, MILLER W, SNOVER DC: Significance of mucosal vs. salivary gland changes in lip biopsies in the diagnosis of chronic graft- vs-host disease. Arch. Pathol Lab. Med. (1989) 113:932\u2013934.","journal-title":"salivary gland changes in lip biopsies in the diagnosis of chronic graft- vs-host disease. Arch. Pathol Lab. Med."},{"key":"e_1_2_1_96_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0889-857X(21)00091-0"},{"key":"e_1_2_1_97_1","first-page":"77","article-title":"Sarcoidosis in a patient presenting with clinical and histopathological features in primary Sjogren's syndrome","volume":"14","author":"MELSOM RD","year":"1988","unstructured":"MELSOM RD, SPEIGHT PM, RYAN J, PERRY JD: Sarcoidosis in a patient presenting with clinical and histopathological features in primary Sjogren's syndrome. Ann. Rheum. Dis. (1988) 14:77\u2013103.","journal-title":"Ann. Rheum. Dis."},{"key":"e_1_2_1_98_1","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(92)91645-O"},{"key":"e_1_2_1_99_1","doi-asserted-by":"publisher","DOI":"10.3109\/03009748909095399"},{"key":"e_1_2_1_100_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0889-857X(21)00314-8"},{"key":"e_1_2_1_101_1","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.23.8.690"},{"key":"e_1_2_1_102_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780310512"},{"key":"e_1_2_1_103_1","first-page":"621","article-title":"A prospective study comparing incisional labial to incisional parotid biopsies in detection and confirmation of sarcoidosis, Sjogren's syndrome sialosis and lymphoma","volume":"15","author":"MARX RE","year":"1988","unstructured":"MARX RE, HARTMANN KS, RETHMANN KV: A prospective study comparing incisional labial to incisional parotid biopsies in detection and confirmation of sarcoidosis, Sjogren's syndrome sialosis and lymphoma. Rheumatol (1988) 15:621\u2013629.","journal-title":"Rheumatol"},{"key":"e_1_2_1_104_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.51.6.777"},{"key":"e_1_2_1_105_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0889-857X(21)00313-6"},{"key":"e_1_2_1_106_1","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.68.9.674"},{"key":"e_1_2_1_107_1","unstructured":"MADDISON PJ: Autoantibodies in Sjogren's syndrome: their origins and pathological consequences. In: Autoimmune Diseases-Focus on Spigren's Syndrome. Isenberg DA Horsfall AC (Eds) Bios Scientific Publishers Oxford UK (1994):89\u2013100."},{"key":"e_1_2_1_108_1","doi-asserted-by":"crossref","unstructured":"MOLLER K MANTHORPE R PERMIN H HOIER-MADSEN OXHOLM P: Circulating IgM Rheumatoid Factors in Patients with Primary Sjogren's Syndrome. Scant\/. J. Rheum. (1988) (Suppl. 75):265\u2013268.","DOI":"10.3109\/03009748809096775"},{"key":"e_1_2_1_109_1","doi-asserted-by":"crossref","unstructured":"MARKUSSE HM OTTEN HG VROOM TM etal.: rheumatoid factor isotypes in serum and salivary fluid of patients with primary Sjogren's syndrome. Immunolog. Immunpathol (1993) 66(1):26\u201332.","DOI":"10.1006\/clin.1993.1004"},{"key":"e_1_2_1_110_1","doi-asserted-by":"publisher","DOI":"10.1016\/0896-8411(89)90189-3"},{"key":"e_1_2_1_111_1","doi-asserted-by":"crossref","unstructured":"TAN EM FELTKAMP TE SMOLEN JS et al: Range of antinuclear antibodies in 'healthy' individuals. Arthritis Rheum. (1997) 40(9):1601\u20131611. \u2022Interesting study demonstrating a high prevalence of positive antinuclear antibodies in 'healthy' individuals.","DOI":"10.1002\/art.1780400909"},{"key":"e_1_2_1_112_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/30.6.437"},{"key":"e_1_2_1_113_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-98-2-155"},{"key":"e_1_2_1_114_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/36.9.969"},{"key":"e_1_2_1_115_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780281205"},{"key":"e_1_2_1_116_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2249.1999.00778.x"},{"key":"e_1_2_1_117_1","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(199812)41:12<2238::AID-ART20>3.0.CO;2-V"},{"key":"e_1_2_1_118_1","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0714.2001.300101.x"},{"key":"e_1_2_1_119_1","doi-asserted-by":"publisher","DOI":"10.1053\/gast.1996.v110.pm8613065"},{"key":"e_1_2_1_120_1","first-page":"137","article-title":"Autoimmune thyroiditis and primary Sjogren's syndrome: clinical and laboratory evidence of the coexistence of the two diseases","volume":"9","author":"HANSEN BU","year":"1991","unstructured":"HANSEN BU, ERICSSON UB, HENRICSSON V, LARSSON A, MANTHORPE R, WARFVINGE G: Autoimmune thyroiditis and primary Sjogren's syndrome: clinical and laboratory evidence of the coexistence of the two diseases. Clin. Exp. Rheumatol (1991) 9:137\u2013141.","journal-title":"Clin. Exp. Rheumatol"},{"key":"e_1_2_1_121_1","doi-asserted-by":"crossref","unstructured":"BARENDREGT PJ VISSER MRM SMETS EMA etal.: Fatigue in primary Sjogren's syndrome. Ann. Rheum. Dis. (1998) 57(5):291\u2013295.","DOI":"10.1136\/ard.57.5.291"},{"key":"e_1_2_1_122_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/32.12.1072"},{"key":"e_1_2_1_123_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/32.7.609"},{"key":"e_1_2_1_124_1","first-page":"139","article-title":"Sjogren's syndrome","volume":"36","author":"MANTHORPE R","year":"1981","unstructured":"MANTHORPE R, FROST-LARSEN K, ISAGER H et al.: Sjogren's syndrome. A review with emphasis on immunological features. Allergy (1981) 36:139\u2013153.","journal-title":"A review with emphasis on immunological features. Allergy"},{"key":"e_1_2_1_125_1","doi-asserted-by":"crossref","unstructured":"KATZ J MARMARY A DANON Y. Drug allergy in Sjogren's syndrome. Lancet (1991) (Letter):239.","DOI":"10.1016\/0140-6736(91)92202-D"},{"key":"e_1_2_1_126_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2249.1990.tb05183.x"},{"key":"e_1_2_1_127_1","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(92)92549-U"},{"issue":"2","key":"e_1_2_1_128_1","first-page":"373","article-title":"WAHREN-HERLENIUS M, MANTHORPE R: Primary Sjogren's syndrome - treatment of fetal incomplete atrioventricular block with dexamethasone","volume":"28","author":"THEANDER E","year":"2001","unstructured":"THEANDER E, BRUCATO A, GUDMUNDSSON S, SALOMONSSON S, WAHREN-HERLENIUS M, MANTHORPE R: Primary Sjogren's syndrome - treatment of fetal incomplete atrioventricular block with dexamethasone. RheumataL (2001) 28(2):373\u2013376.","journal-title":"RheumataL"},{"key":"e_1_2_1_129_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-76-3-375"},{"key":"e_1_2_1_130_1","doi-asserted-by":"publisher","DOI":"10.1016\/0031-9384(94)00211-M"},{"key":"e_1_2_1_131_1","doi-asserted-by":"crossref","unstructured":"TSIANOS EB VASAKOS S DROSOS AA et al.: The gastrointestinal involvement in primary Sjogren's syndrome. Land. RheumataL (1986) (Suppl. 61):151\u2013155.","DOI":"10.1080\/15027732.1986.12461401"},{"key":"e_1_2_1_132_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF02407153"},{"key":"e_1_2_1_133_1","unstructured":"BERTRAM U: Xerostomia. Clinical aspects pathology and pathogenesis. (Thesis). Acta OdontaL Scam\/. (1967) 25\\(Suppl. 49)."},{"key":"e_1_2_1_134_1","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.33.3.282"},{"key":"e_1_2_1_135_1","doi-asserted-by":"publisher","DOI":"10.1016\/0030-4220(89)90218-1"},{"issue":"5","key":"e_1_2_1_136_1","first-page":"300","article-title":"Prevalence, density, and manifestations of oral Candida albicans in patients with Sjogren's syndrome","volume":"26","author":"RHODUS NL","year":"1997","unstructured":"RHODUS NL, BLOMQUIST C, LILJEMARK W, BEREUTER J: Prevalence, density, and manifestations of oral Candida albicans in patients with Sjogren's syndrome. j OtalaryrigaL (1997) 26(5):300\u2013305.","journal-title":"j OtalaryrigaL"},{"key":"e_1_2_1_137_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1079-2104(98)90151-2"},{"issue":"1","key":"e_1_2_1_138_1","first-page":"110","article-title":"Oral microbial flora in Sjogren's syndrome","volume":"26","author":"ALMSTAHL A","year":"1999","unstructured":"ALMSTAHL A, KRONELD U, TARKOWSKI A, WIKSTROM M: Oral microbial flora in Sjogren's syndrome. RheumataL (1999) 26(1):110\u2013114.","journal-title":"RheumataL"},{"key":"e_1_2_1_139_1","doi-asserted-by":"publisher","DOI":"10.1016\/0030-4220(94)90143-0"},{"key":"e_1_2_1_140_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0003-9969(01)00003-6"},{"key":"e_1_2_1_141_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-051X.1990.tb01099.x"},{"key":"e_1_2_1_142_1","unstructured":"MUTLU S PORTER SR RICHARDS A PORTER KM MADDISON P SCULLY C: Periodontal disease in Sjogren's syndrome. Chu. Exp. Rheum. (1991) 9:317. Abstract."},{"key":"e_1_2_1_143_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1079-2104(97)90144-X"},{"key":"e_1_2_1_144_1","doi-asserted-by":"publisher","DOI":"10.1177\/08959374960100011801"},{"key":"e_1_2_1_145_1","doi-asserted-by":"publisher","DOI":"10.1080\/030097400750001761"},{"key":"e_1_2_1_146_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0404.1994.tb01629.x"},{"issue":"1","key":"e_1_2_1_147_1","first-page":"165","article-title":"Anxiety and Depression in patients with primary Sjogren's syndrome","volume":"27","author":"VALTYSDOTTIR ST","year":"2000","unstructured":"VALTYSDOTTIR ST, GUDBJORNSSON B, LINDQUIST U, HALLGREN R, HETTA J: Anxiety and Depression in patients with primary Sjogren's syndrome. RheumataL (2000) 27(1):165\u2013169.","journal-title":"RheumataL"},{"key":"e_1_2_1_148_1","doi-asserted-by":"crossref","unstructured":"REVEILLE JD ARNETT FC: The immunogenetics of Sjogren's syndrome. In: .5:Ogren's Syndrome. Fox RI (Ed.). Rheum. Dis. Chu. North Am. (1992) 18:539\u2013550.","DOI":"10.1016\/S0889-857X(21)00315-X"},{"key":"e_1_2_1_149_1","unstructured":"SULLIVAN DA: Sex Hormones and Sjogren's Syndrome. j RheumataL (1997) 24\\(Suppl. 50):17\u201332."},{"issue":"6","key":"e_1_2_1_150_1","first-page":"1259","article-title":"Low serum dehydroepiandrosterone sulfate in women with Sjogren's syndrome as an isolated sign of impaired HPA axis function","volume":"28","author":"VALTYSDOTTIR ST","year":"2001","unstructured":"VALTYSDOTTIR ST, WIDE L, HALLGREN R: Low serum dehydroepiandrosterone sulfate in women with Sjogren's syndrome as an isolated sign of impaired HPA axis function. RheumataL (2001) 28(6):1259\u20131265.","journal-title":"RheumataL"},{"key":"e_1_2_1_151_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1601-0825.2000.tb00136.x"},{"key":"e_1_2_1_152_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.130.1.203"},{"key":"e_1_2_1_153_1","doi-asserted-by":"crossref","unstructured":"SAITO I TERAUCHI K SHIMUTA Met al.: Expression of cell adhesion molecules in the salivary and lacrimal glands of Sjogren's syndrome. j Chu. Lab. Anal. (1993) 7(3): 180\u2013187.","DOI":"10.1002\/jcla.1860070309"},{"key":"e_1_2_1_154_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780370710"},{"key":"e_1_2_1_155_1","doi-asserted-by":"publisher","DOI":"10.1006\/clin.1998.4556"},{"key":"e_1_2_1_156_1","doi-asserted-by":"publisher","DOI":"10.1038\/labinvest.3780215"},{"key":"e_1_2_1_157_1","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(200102)44:2<408::AID-ANR60>3.0.CO;2-0"},{"key":"e_1_2_1_158_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1398-9995.1964.tb03284.x"},{"key":"e_1_2_1_159_1","first-page":"1","article-title":"Antibodies to salivary duct cells and other autoantibodies in patients with Sjogren's syndrome","volume":"3","author":"FELTKAMP TEW, VAN ROSSUM AL","year":"1968","unstructured":"FELTKAMP TEW, VAN ROSSUM AL: Antibodies to salivary duct cells and other autoantibodies in patients with Sjogren's syndrome. Chu. Exp. Immunol. (1968) 3:1\u201316.","journal-title":"Chu. Exp. Immunol."},{"key":"e_1_2_1_160_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0714.1995.tb01168.x"},{"key":"e_1_2_1_161_1","doi-asserted-by":"crossref","unstructured":"HANEJI N NAKAMURA T TAKIO K et al.: Identification of alpha-fodrin as a candidate autoantigen in primary Sjogren's syndrome. Science (1997) 276(5312)604-607. \u2022\u2022Identification of an apoptotic breakdownproduct of the cytoskeletal molecule (fodrin) as a target antigen in the submandibular gland of an animal model.","DOI":"10.1126\/science.276.5312.604"},{"key":"e_1_2_1_162_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780400920"},{"key":"e_1_2_1_163_1","unstructured":"VENABLES PJW RIGBY SP: Viruses in the Etiopathogenesis of Sjogren's Syndrome. Rheumatol (1997) 24\\(Suppl. 50):3\u20135."},{"key":"e_1_2_1_164_1","doi-asserted-by":"publisher","DOI":"10.1016\/0896-8411(89)90170-4"},{"key":"e_1_2_1_165_1","doi-asserted-by":"publisher","DOI":"10.3109\/03009748809105275"},{"key":"e_1_2_1_166_1","first-page":"1358","article-title":"Morphometric analysis of secretory glands in Sjogren's syndrome","volume":"146","author":"ANDOH Y","year":"1993","unstructured":"ANDOH Y, SHIMURA S, SAWAI T, SASKI H, TAKISHIMA T, SHIRATO K: Morphometric analysis of secretory glands in Sjogren's syndrome. Tohokuj Esp. Med. (1993) 146:1358\u20131362.","journal-title":"Tohokuj Esp. Med."},{"key":"e_1_2_1_167_1","doi-asserted-by":"crossref","unstructured":"HUMPHREYS-BEHER MG BRAYER J YAMACHIKA S PECK AB JONSSON R: An alternative perspective to the immune response in autoimmune exocrinopathy: induction of functional quiescence rather than destructive autoaggression. Scand. Immunol (1999) 49:7-10. **Excellent review on the possibility that the pathogenesis of SS comprises immune-mediated neurohormonal events.","DOI":"10.1046\/j.1365-3083.1999.00490.x"},{"key":"e_1_2_1_168_1","unstructured":"LOOMS DK TRITSARIS K DISSING S JORGENSEN T NAUNTOFTE B: Regulation of salivary secretion: interactions between signalling pathways. In: Oral Biology at the Turn of the Century: Misconceptions Truths Challenges and Prospects. Guggenheim B Shapiro S (Eds.) Karger AG Basel (1998):179\u2013188."},{"key":"e_1_2_1_169_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)61694-7"},{"key":"e_1_2_1_170_1","doi-asserted-by":"publisher","DOI":"10.1038\/labinvest.3780221"},{"key":"e_1_2_1_171_1","doi-asserted-by":"publisher","DOI":"10.3109\/08916939209148458"},{"key":"e_1_2_1_172_1","first-page":"107","article-title":"Intracellular calcium signalling in mouse submandibular acinar cells co-cultured with activated splenic lymphocytes","volume":"509","author":"DAWSON LJ","year":"1998","unstructured":"DAWSON LJ, SMITH PM: Intracellular calcium signalling in mouse submandibular acinar cells co-cultured with activated splenic lymphocytes. J. Physiol (1998) 509:107.","journal-title":"J. Physiol"},{"key":"e_1_2_1_173_1","doi-asserted-by":"crossref","unstructured":"BACMAN S STERIN-BORDA L CAMUSSO JJ ARANA R HUBSCHER 0 BORDA E: Circulating antibodies against rat parotid M3 muscarinic receptors in primary Sjogren's syndrome. Chu. Exp. Immunol (1996) 104:454-459. \u2022\u2022Interesting study suggesting thatcirculating antibodies interfere with the M3 muscarinic receptors and thereby prevent an adequate response of the exocrine glands to neural stimulation.","DOI":"10.1046\/j.1365-2249.1996.42748.x"},{"key":"e_1_2_1_174_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.95.13.7538"},{"key":"e_1_2_1_175_1","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(200007)43:7<1647::AID-ANR31>3.0.CO;2-P"},{"key":"e_1_2_1_176_1","doi-asserted-by":"publisher","DOI":"10.14219\/jada.archive.1993.0064"},{"issue":"5","key":"e_1_2_1_177_1","first-page":"736","article-title":"SINDET-PEDERSEN S: Outcome of treatment with implant-retained dental prostheses","volume":"14","author":"ISIDOR F","year":"1999","unstructured":"ISIDOR F, BRONDUM K, HANSEN HJ, JENSEN J, SINDET-PEDERSEN S: Outcome of treatment with implant-retained dental prostheses. Int. J. Oral Maxillofac. Implants (1999) 14(5):736\u2013743.","journal-title":"Int. J. Oral Maxillofac. Implants"},{"key":"e_1_2_1_178_1","first-page":"865","article-title":"0, TURNBULL RS: A review of the literature on the use of chlorhexidine in dentistry","volume":"112","author":"FARDAL","year":"1986","unstructured":"FARDAL 0, TURNBULL RS: A review of the literature on the use of chlorhexidine in dentistry. JADA (1986) 112:865\u2013869.","journal-title":"JADA"},{"key":"e_1_2_1_179_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1601-0825.2000.tb00316.x"},{"key":"e_1_2_1_180_1","doi-asserted-by":"publisher","DOI":"10.1016\/0030-4220(92)90066-Y"},{"key":"e_1_2_1_181_1","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.159.2.174"},{"key":"e_1_2_1_182_1","first-page":"288","article-title":"Randomized, placebo controlled trial of SNI-2011, a novel M3 muscarinic receptor agonist, for the treatment of Sjogren's syndrome","volume":"41","author":"FOX R","year":"1998","unstructured":"FOX R, PENTRONE J, CONDEMI R, FIFE P: Randomized, placebo controlled trial of SNI-2011, a novel M3 muscarinic receptor agonist, for the treatment of Sjogren's syndrome. Arthritis Rheum. (1998) 41:288.","journal-title":"Arthritis Rheum"},{"key":"e_1_2_1_183_1","doi-asserted-by":"publisher","DOI":"10.1016\/0030-4220(83)90096-8"},{"key":"e_1_2_1_184_1","doi-asserted-by":"crossref","unstructured":"SCHIODT M OXHOLM P JACOBSEN A. Treatment of xerostomia in patients with primary Sjogren's with Sulfarlem. Scand. I Rheumatol (1986) (Suppl. 61):250\u2013252.","DOI":"10.1080\/15027732.1986.12461422"},{"key":"e_1_2_1_185_1","first-page":"943","volume":"19","author":"SHIP JA","year":"1999","unstructured":"SHIP JA, FOX PC, MICHALEK JE, CUMMINS MJ, RICHARDS AB. Treatment of primary Sjogren's syndrome with low-dose natural human interferon-alpha administered by the oral mucosa route: a Phase II clinical trial. IFN Protocol Study Group. J. Interferon Cytokine Res. (1999) 19:943\u2013951.","journal-title":"RICHARDS AB. Treatment of primary Sjogren's syndrome with low-dose natural human interferon-alpha administered by the oral mucosa route: a Phase II clinical trial. IFN Protocol Study Group. J. Interferon Cytokine Res."},{"key":"e_1_2_1_186_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.1.6127.1579"},{"key":"e_1_2_1_187_1","doi-asserted-by":"crossref","unstructured":"FOX RI DIXON R GUARRASI V KRUBEL S: Treatment of primary Sjogren's syndrome with hydroxychloroquine: a retrospective open-label study. Lupus (1996) 5\\(Supp1.1):S31\u201336.","DOI":"10.1177\/0961203396005001081"},{"key":"e_1_2_1_188_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.45.9.732"},{"key":"e_1_2_1_189_1","first-page":"53","article-title":"Nandrolone decanoate in primary Sjogren's syndrome: a double blind pilot study","volume":"6","author":"DROSOS AA","year":"1996","unstructured":"DROSOS AA, VAN VLIET-DASCALOPOULOU E, ANDONOPOULOS AP et al.: Nandrolone decanoate in primary Sjogren's syndrome: a double blind pilot study. CM]. Exp. Rheumatol. (1996) 6:53\u201357.","journal-title":"CM]. Exp. Rheumatol."},{"issue":"9","key":"e_1_2_1_190_1","first-page":"814","article-title":"APPELBOOM T","volume":"38","author":"STEINFELD SD","year":"1999","unstructured":"STEINFELD SD, DEMOLS P, VAN VOOREN JP, COGAN E, APPELBOOM T. Zidovudine in primary Sjogren's syndrome. Rheumatology (1999) 38(9) 814\u2013817.","journal-title":"Zidovudine in primary Sjogren's syndrome. Rheumatology"},{"issue":"5","key":"e_1_2_1_191_1","first-page":"533","article-title":"PALMVANG I, H\u00d8IER-MADSEN: LongoVital in the treatment of Sjogren's syndrome","volume":"17","author":"PEDERSEN A","year":"1999","unstructured":"PEDERSEN A, GERNER N, PALMVANG I, H\u00d8IER-MADSEN: LongoVital in the treatment of Sjogren's syndrome. CM]. Exp. Rheumatol. (1999) 17(5):533\u2013538.","journal-title":"CM]. Exp. Rheumatol."},{"key":"e_1_2_1_192_1","doi-asserted-by":"publisher","DOI":"10.1016\/0030-4220(93)90172-Z"},{"key":"e_1_2_1_193_1","unstructured":"PEDERSEN AM ANDERSEN TORPET L REIBEL J HOLMSTRUP E NAUNTOFTE B: Primary Sjogren's syndrome and oral lichen planus: effects of colostrum-containing dentrifrices. j. Dent. Res. (2001) 80(9):1267. Abstract."},{"key":"e_1_2_1_194_1","first-page":"763","article-title":"Use of alternative medicine by Sjogren's syndrome patients","volume":"16","author":"PAL B","year":"1998","unstructured":"PAL B: Use of alternative medicine by Sjogren's syndrome patients. Clin. Exp. Rheumatol. (Letter) (1998) 16:763.","journal-title":"Clin. Exp. Rheumatol. (Letter)"}],"container-title":["Expert Opinion on Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1517\/14656566.2.9.1415","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T22:01:08Z","timestamp":1770415268000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1517\/14656566.2.9.1415"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,9]]},"references-count":193,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2001,9]]}},"alternative-id":["10.1517\/14656566.2.9.1415"],"URL":"https:\/\/doi.org\/10.1517\/14656566.2.9.1415","relation":{},"ISSN":["1465-6566","1744-7666"],"issn-type":[{"value":"1465-6566","type":"print"},{"value":"1744-7666","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,9]]}}}